CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,102 enrolled
Drug / intervention
Sampling of 15ml blood +1 moreprocedure
Likely dose
Sampling of 15ml bloodfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00878813
NCT00878813N/ACompleted

Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk-study

Insel Gruppe AG, University Hospital Bern·observational·Posted Apr 9, 2009·Updated Nov 10, 2011

In Brief

An observational study evaluating Sampling of 15ml blood and Blood-Sampling for Stroke and Transient Ischemic Attack. Completed, enrolled 1,102 participants across 4 sites in 2 countries.

Detailed Summary

Prospective observational multicenter study to evaluate copeptin as a prognostic marker in patients with an acute cerebrovascular event. It includes four groups of patients, mainly depending on type of initial therapy (intra-arterial thrombolysis, intravenous thrombolysis, conservative treatment, TIA). The study takes place at the Emergency and neurological Department of the University of Bern, Switzerland; Department of Neurology, Goethe University of Frankfurt a.M. (Germany). Further participating centers are under discussion

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany, Switzerland

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 9, 2009
Enrollment StartMar 1, 2009
Primary CompletionApr 1, 2011
Study CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 17.2 years ago

Interventions

Sampling of 15ml bloodprocedure

On admission, 2 x 7.5ml blood tubes will be drawn during the first routine blood sampling

Blood-Samplingprocedure

On day 1 after intra-arterial thrombolysis, 2 x 7.5ml blood tubes on the following routine blood-sampling will be drawn.